Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1802-1808

  Eggert, Angelika ^a   Grotzer, Michael A ^a   Ikegaki, Naohiko ^a   Liu, Xing Ge ^a   Evans, Audrey E ^a   Brodeur, Garrett M ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR; PROTEIN TYROSINE KINASE A; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ANIMALS; CELL COMMUNICATION; CELL DIVISION; CELL MOVEMENT; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; PHOSPHORYLATION; RECEPTOR, TRKA; RECEPTOR, TRKB; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037086267     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. What is the evidence that tumors are angiogenesis dependent?
2. Vascular endothelial growth factor is a secreted angiogenic mitogen
3. Angiogenic factors
4. Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival
5. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
6. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
7. Transforming growth factor-αinduced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation
8. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
9. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src
10. Mutant ras oncogenes up-regulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
11. TrkA expression in neuroblastomas: A new prognostic marker with biological and clinical significance
12. Expression and function of Trk-B and BDNF in human neuroblastomas
13. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastomas
14. Coexpression of messenger RNA for Trk proto-oncogene and low affinity nerve growth factor receptor in neuroblastomas with favorable prognosis
15. Expression of TrkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo
16. Transfection of TrkA into human neuroblastoma cells restores their ability to differentiate in response to NGF
17. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells
18. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
19. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma
20. Morphology, growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture
21. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells
22. A relative quantitative RT-PCR protocol for TrkB expression in neuroblastoma using GAPD as an internal control
23. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
24. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo
25. Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation
26. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after co-injection with Matrigel
27. An α-D-galactosyl-binding lectin from Bandeiraea simplicifolia seeds. Isolation by affinity chromatography and characterization
28. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
29. A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblastic growth factor
30. Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia
31. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
32. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
33. The role of vascular endothelial growth factor in pathological angiogenesis
34. TrkA expression decreases the in vivo aggressiveness of C6 glioma cells
35. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression
36. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo